首页 News 正文

Novartis' kidney product portfolio makes its debut at the China International Import Expo, and the company stated that it will actively promote the product's launch

海角七号
131 0 0

The 7th China International Import Expo (CIIE) is currently being held. The reporter saw at the scene that Novartis' innovative drug combination for the treatment of IgA nephropathy (IgAN), including atorvastatin and fexostat (Ipropan hydrochloride capsules), made its first joint appearance. The reporter further learned from Novartis that Novartis plans to launch a "combination punch" in the field of kidney disease. Atractylodes, Ipropan Hydrochloride Capsules, and another investigational product Zigakibart will be important components of Novartis' product pipeline in the field of kidney disease, covering six major indications and rewriting the diagnosis and treatment status of IgA nephropathy and other kidney diseases in China, "the company said.
Further information shows that atorvastatin is the first non immune, highly selective IgAN precision therapy drug submitted for market in China. Ipropan Hydrochloride Capsules received accelerated approval from the US Food and Drug Administration in August this year to reduce proteinuria in adult IgA nephropathy patients at risk of rapid progression. It is currently the world's first complement bypass pathway inhibitor approved for this indication; At present, the indication of using Ipropan Hydrochloride Capsules for the treatment of paroxysmal nocturnal hemoglobin (PNH) has been approved in China, and the application for expanding indications in the field of kidney disease has also been accepted by the China National Medical Products Administration.
Li Yao, President and Managing Director of Novartis China, stated that the new kidney product portfolio showcased at the CIIE is expected to provide more accurate and safe solutions for the treatment of kidney diseases in China. "We will actively promote the simultaneous launch of these innovative drugs domestically and globally, and use 'Chinese speed' to benefit more kidney disease patients
CandyLake.com 系信息发布平台,仅提供信息存储空间服务。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
您需要登录后才可以回帖 登录 | 立即注册

本版积分规则

  •   知名做空机构香橼研究(Citron Research)周四(11月21日)在社交媒体平台X上发布消息称,该公司已决定做空“比特币大户”微策略(Microstrategy)这家公司,并认为该公司已经将自己变身成为一家比特币投资基金 ...
    caffycat
    8 小时前
    支持
    反对
    回复
    收藏
  •   每经AI快讯,11月20日,文远知行宣布旗下自动驾驶环卫车S6与无人扫路机S1分别在新加坡滨海湾海岸大道与滨海艺术中心正式投入运营。据介绍,这是新加坡首个商业化运营的自动驾驶环卫项目。 ...
    star8699
    前天 19:48
    支持
    反对
    回复
    收藏
  •   上证报中国证券网讯(记者王子霖)11月20日,斗鱼发布2024年第三季度未经审计的财务报告。本季度斗鱼依托丰富的游戏内容生态,充分发挥主播资源和新业务潜力,持续为用户提供高质量的直播内容及游戏服务,进一步 ...
    goodfriendboy
    前天 20:09
    支持
    反对
    回复
    收藏
  •   人民网北京11月22日电 (记者栗翘楚、任妍)2024广州车展,在新能源汽车占据“半壁江山”的同时,正加速向智能网联新能源汽车全面过渡,随着“端到端”成为新宠,智能驾驶解决方案成为本届广州车展各大车企竞 ...
    3233340
    2 小时前
    支持
    反对
    回复
    收藏
海角七号 注册会员
  • 粉丝

    0

  • 关注

    1

  • 主题

    29